Answers are grounded in this paper and cite their sources.
Regular measurements of oxygen (O 2 ) and carbon dioxide (CO 2 ) are crucial for evaluation of the respiratory status in patients with moderate and advanced COPD. While O 2 monitoring is well established by pulse oximetry, there are still no established methods for non-invasive home measurements of CO 2 in patients during spontaneous breathing. Until now, patients must consult specialists or clinics for standardized procedures such as blood gas analysis (BGA) or transcutaneous capnometry (tCO 2 ). We therefore investigated a new hand-held device (Lumetry), based on volumetric and spirometric capnography with modernized algorithms for COPD patients during calm, spontaneous breathing (exclusion criterion RR > 21/min) and optimized beathing maneuvers. The aim of the study was to assess (1) the safety and usability of Lumetry and (2) agreement with well-established measurement methods BGA und tCO 2 . In this single-center prospective study, electively admitted patients with COPD GOLD 3 or 4 underwent spirometric capnography CO 2 measurements (petCO 2 ). Patients were stratified according to presence of hypercapnia as defined by a daytime paCO 2 >45 mmHg. End-tidal (petCO 2 ) values were translated to pCO 2 per device specific algorithms. Different breathing maneuvers (rested breathing, one deep exhalation, two deep in- and exhalations), were performed and the Lumetry results were compared with standardized CO 2 procedures in capillary blood gas analysis (Siemens, RAPIDpoint 500) and transcutaneous CO 2 measurement (Radiometer TCM5). Agreement between measurement methods were assessed using Bland-Altman analysis calculating mean bias and limits of agreement (LoA) 57 patients (32 women) were included in the analysis of whom 30 (52.6%) had hypercapnia. In the overall cohort, Lumetry slightly underestimated pCO 2 values compared to capillary blood gas analysis (CBG) during rested breathing (mean bias 6.1 mmHg, 95% LoA − 2.6 to 14.8 mmHg). Best agreement was observed for the deep breath mean maneuver (bias 2.1 mmHg, LoA − 8.2 to 12.4 mmHg). When stratified by hypercapnia status, the same pattern was observed. Lumetry showed similar agreement to CBG when compared to standard transcutaneous CO 2 levels (bias − 1.7 mmHg, LoA − 10.4 to 7.0 mmHg). There were no safety restrictions and the Lumetry device was easy to handle. Capnographic Lumetry measurements showed acceptable limits of agreement to capillary blood gas analysis. They furthermore proved non-inferior to transcutaneous CO 2 measurements. Results were consistent in hypercapnic and non-hypercapnic COPD patients and optimized by adapted deep breathing maneuvers. The Lumetry device was safe and easy to use. These promising results highlight its potential for home-based CO 2 monitoring and early detection of hypercapnic exacerbations.
No takes yet. Share an insight, caveat, or question.
Schellenberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: